[HTML][HTML] BRAF Alteration in Central and Peripheral Nervous System Tumors
K Srinivasa, KA Cross, S Dahiya - Frontiers in Oncology, 2020 - frontiersin.org
… observed in numerous primary central nervous system tumors as … -BRAF treated with an
analog of vemurafenib exhibit … cases of dramatic and sometimes-sustained response to BRAFi …
analog of vemurafenib exhibit … cases of dramatic and sometimes-sustained response to BRAFi …
Targeted therapy of BRAF V600E‐mutant histiocytic sarcoma: A case report and review of the literature.
B Branco, T Comont, L Ysebaert… - European Journal …, 2019 - search.ebscohost.com
… , we think that the remission observed is due to the BRAF inhibition. Optimal duration of …
Dramatic response of a BRAF V600E‐mutated primary CNS histiocytic sarcoma to vemurafenib. …
Dramatic response of a BRAF V600E‐mutated primary CNS histiocytic sarcoma to vemurafenib. …
[HTML][HTML] BRAF V600E expression in histiocytic sarcoma associated with splenic marginal zone lymphoma: a case report
JL Vaughn, CE Freitag, JA Hemminger… - Journal of Medical Case …, 2017 - Springer
… of bone marrow and central nervous system involvement, … of BRAF V600E expression, we
may have utilized vemurafenib in … as vemurafenib in the treatment of patients with this disorder. …
may have utilized vemurafenib in … as vemurafenib in the treatment of patients with this disorder. …
Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
…, C van den Bos, AGS van Halteren, H Histiocytic… - Blood Neoplasia, 2024 - Elsevier
… the diagnoses of histiocytic sarcoma (HS), Langerhans cell sarcoma 192 and interdigitating
dendritic cell sarcoma, … We also thank Roche for providing vemurafenib and/or cobimetinib. …
dendritic cell sarcoma, … We also thank Roche for providing vemurafenib and/or cobimetinib. …
A rare case of primary central nervous system histiocytic sarcoma harboring a novel ARHGAP45::BRAF fusion: a case report and literature review
L Zhang, G Zhang, H Zheng, B Jiang, Y Ju, Q Duan… - Brain Tumor …, 2024 - Springer
… published cases of primary central nervous system histiocytic sarcoma (PCNSHS) … It has
been demonstrated that vemurafenib treatment resulted in a 3-month response in a BRAF p.…
been demonstrated that vemurafenib treatment resulted in a 3-month response in a BRAF p.…
[HTML][HTML] Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma
V Shanmugam, GK Griffin, ED Jacobsen… - Modern Pathology, 2019 - Elsevier
… [27] treated a patient with isolated central nervous system histiocytic sarcoma harboring a
BRAF p.V600E mutation with vemurafenib who had a dramatic clinical and radiologic …
BRAF p.V600E mutation with vemurafenib who had a dramatic clinical and radiologic …
Histiocytic Tumors of the CNS
CR Lacruz, E Leonardo - Central Nervous System Tumors: Diagnostic …, 2024 - Springer
… Histiocytic sarcoma (HS) is a malignant hematopoietic … On imaging, HS mimics a malignant
primary CNS tumor, with … V600E mutations may respond to inhibitors (eg, vemurafenib)…
primary CNS tumor, with … V600E mutations may respond to inhibitors (eg, vemurafenib)…
Histiocytic tumours of the central
O Abla, J Picarsic - Oxford Textbook of Neurohaematology, 2024 - books.google.com
… response to the BRAF-V600E inhibitor vemurafenib was reported in a refractory case of
BRAF-V600E-mutated primary CNS-… for histiocytic sarcoma of the central nervous system. Leuk …
BRAF-V600E-mutated primary CNS-… for histiocytic sarcoma of the central nervous system. Leuk …
[HTML][HTML] A case of primary histiocytic sarcoma of the central nervous system
R Uno, M Kanzawa, K Tanaka, T Sasayama… - Human Pathology …, 2022 - Elsevier
… Histiocytic sarcoma (HS) is a highly malignant hematopoietic neoplasm that rarely arises in
the central nervous system (CNS)… Histiocytic sarcoma (HS) is a rare malignant hematopoietic …
the central nervous system (CNS)… Histiocytic sarcoma (HS) is a rare malignant hematopoietic …
[HTML][HTML] Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression …
… Here, we present a case of primary CNS HS with leptomeningeal spread treated with tri-…
a dramatic clinical and radiographic response with vemurafenib, though the response was not …
a dramatic clinical and radiographic response with vemurafenib, though the response was not …